CJC-1295 + Ipamorelin (5/5 mg No DAC)
CJC-1295 and Ipamorelin is a synergistic research blend of two growth hormone secretagogues. CJC-1295 is a synthetic Growth Hormone-Releasing Hormone (GHRH) analog, and Ipamorelin is a selective Growth Hormone Releasing Peptide (GHRP) and ghrelin receptor agonist. Together, they target distinct pathways in the pituitary gland and hypothalamus to stimulate a pulsatile, enhanced release of growth hormone.
Product Specifications
| Specification |
CJC-1295 (No DAC) |
Ipamorelin |
| Chemical Formula |
C152H252N44O42 |
C38H49N9O5 |
| Molecular Weight |
3367.95 g/mol |
711.86 g/mol |
| CAS Number |
863288-34-0 |
170851-70-4 |
| PubChem CID |
91976842 |
9831659 |
| Purity |
>99% (Guaranteed) |
| Physical State |
Lyophilized Powder (Sterile Vial) |
Key Research Applications
- Researching synergistic double-pathway growth hormone secretagogue activity.
- Studying GHRH and ghrelin receptor co-activation in anterior pituitary somatotrophs.
- Exploring impacts on fat loss (lipolysis) and muscle repair pathways in animal models.
- Investigating the influence of growth hormone secretagogue blends on cellular repair and longevity.
Reconstitution & Reagent Handling
Reconstitute with sterile bacteriostatic water. Swirl gently; do not shake.
Storage & Stability
Store lyophilized powder at ≤8°C. Store reconstituted blend refrigerated at 2°C to 8°C.
RESEARCH USE ONLY: This product is a high-purity laboratory chemical. It is synthesized and supplied strictly for laboratory research, in vitro studies, and experimental use. This product is not approved for human or veterinary use, diagnostic procedures, or therapeutic administration.
